Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 13 Jul, 08:00 pm
Twilio (NYSE: TWLO) Receives Analyst Upgrade and Strong Buy Rating Stifel Nicolaus upgraded Twilio (NYSE: TWLO) to " Buy " with a $260.00 price target , suggesting an 18.94% upside. Twilio holds an average "Buy" recommendation of 1.57 from 28 firms, with 20 issuing a " Strong Buy
Despite a downgrade from Citigroup, Lamar Advertising (NASDAQ: LAMR) stock is demonstrating strong performance, reaching a new 52-week high . Zacks Investment Research has upgraded Lamar Advertising to a "Buy" rating, citing optimism about the company's earnings prospects and ide
WD-40 Company (NASDAQ: WDFC) significantly exceeded third-quarter earnings per share (EPS) and revenue expectations, reporting $2.33 EPS against a $1.58 consensus and $195.12 million in revenue against $172.79 million . The robust 24% year-over-year revenue growth was primarily f
Analyst Optimism: Leading financial institutions like Stifel Nicolaus and Bank of America (NYSE: BAC) have issued 'Buy' ratings, with a consensus price target of $150.00 , suggesting a potential 21.78% upside for Shopify (NASDAQ: SHOP) . Key Growth Catalysts: The company's future
Seven & i Holdings (OTC: SVNDY) exceeded earnings per share (EPS) estimates, reporting $0.16 against an expected $0.10 , primarily due to higher gasoline prices. Despite the earnings beat , the company's revenue of $14.63 billion fell short of the $14.97 billion forecast, indicat
nLIGHT, Inc. (NASDAQ:LASR) secured a pivotal U.S. defense contract for developing next-generation laser weapon systems. The initial contract is valued at $44 million , with a potential program ceiling of up to $627 million . The news led to a 27.32% stock surge and positive analy
Analyst firm Bernstein upgraded J.B. Hunt Transport Services, Inc. to Outperform, signaling increased confidence in the transportation and logistics giant. The company anticipates robust second-quarter 2026 performance, with projected revenues between $3.17 billion and $3.21 bill
A Neurocrine Biosciences insider, Delaet Ingrid, executed a significant stock sale totaling $1.51 million . The company demonstrates robust commercial performance with key products like Ingrezza and strategic portfolio expansion. Neurocrine Biosciences (NASDAQ: NBIX) recently rec
Simulations Plus (NASDAQ:SLP) Exceeds Estimates in Q3 2026 Earnings Report Simulations Plus (NASDAQ:SLP) reported earnings per share (EPS) of $0.30 , significantly surpassing the analyst estimate of $0.23. The company achieved revenue of $21.89 million , exceeding the $20.90 mill
Citigroup's upcoming quarterly earnings report on July 14, 2026, is anticipated with analyst forecasts for EPS and revenue . The broader financial sector is experiencing a robust rally, positively impacting banks like Citigroup due to a resilient economy and strong capital market
D.A. Davidson initiated a "Buy" rating for Agco Corp, setting a $160.00 price target, suggesting a potential 41.27% upside for the stock. Agco Corp has consistently surpassed earnings estimates, beating expectations by an average of 65.47% over the last two quarters, indicating r
Wells Fargo & Company (NYSE:WFC) is scheduled to release its Q2 2026 earnings on July 14, 2026, with analysts forecasting a consensus revenue estimate of approximately $21.88 billion and an EPS estimate of $1.74 . The anticipated revenue growth of 4.7% year-over-year is primarily
Strategic Ambition Meets Setback: AstraZeneca (NYSE:AZN) , a leading global pharmaceutical company, aims for $80 billion in annual revenue but faces a significant challenge following a key drug trial failure. Market Reaction Contrasts Analyst Upgrade: Despite Goldman Sachs upgrad
Goldman Sachs (NYSE: GS) is projected to report significant earnings and revenue growth for Q2 2026, with analysts forecasting a 32.60% EPS increase and 13.10% revenue growth . The positive outlook for Goldman Sachs aligns with a strong S&P 500 Financials Sector , which has surge
Exceptional Small-Cap Rally : Julong Holding Limited (NASDAQ: JLHL) recorded the largest gain, rising more than 300% amid extremely heavy trading volume, although no clear new company-specific catalyst was identified. Clinical Data Supports Biotech Gain : Forte Biosciences, Inc.
Ionis Pharmaceuticals (NASDAQ: IONS) Leads Major Stock Decliners After Phase 3 Trial Miss Clinical Trial Setback: Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) experienced the largest decline after a Phase 3 study of eplontersen failed to meet its primary endpoint. Analyst Downgrade
Revenue Growth: Northern Technologies International Corporation (NASDAQ:NTIC) reported record revenue of $24.22 million , a 12.6% increase year-over-year, exceeding analyst expectations for its corrosion prevention and bioplastic solutions. Profitability Challenges: Despite stron
Positive Growth Outlook: Wall Street estimates earnings per share (EPS) of $5.52 ( 11.3% increase) and revenue of $51.06 billion ( 8.4% increase). Positive Analyst Sentiment: The consensus EPS estimate has been revised upward by 1.3% , with increased price targets from UBS and Bo
Headlines provided by Investing.com